Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.51 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.51 |
| ▸ | HPGD | P15428 | 1/20 | 0.51 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.51 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.51 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.51 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6937313 | 0.89 | CYP1A2 (0.53) | CYP1A2CYP3A4CYP2C9HPGDOPRM1 | |
| SCHEMBL6935747 | 0.89 | CYP1A2 (0.53) | CYP1A2CYP3A4CYP2C9HPGDOPRM1 | |
| SCHEMBL6935750 | 0.89 | CYP1A2 (0.53) | CYP1A2CYP3A4CYP2C9HPGDOPRM1 | |
| SCHEMBL6934879 | 0.85 | CYP1A2 (0.51) | CYP1A2CYP3A4CYP2C9HPGDOPRM1 | |
| SCHEMBL6935988 | 0.85 | CYP1A2 (0.55) | CYP1A2CYP3A4CYP2C9HPGDOPRM1 | |
| SCHEMBL6938398 | 0.85 | CYP1A2 (0.55) | CYP1A2CYP3A4CYP2C9HPGDOPRM1 | |
| SCHEMBL6934885 | 0.85 | CYP1A2 (0.51) | CYP1A2CYP3A4CYP2C9HPGDOPRM1 | |
| SCHEMBL6935991 | 0.85 | CYP1A2 (0.55) | CYP1A2CYP3A4CYP2C9HPGDOPRM1 | |
| SCHEMBL6932886 | 0.85 | CYP1A2 (0.47) | CYP1A2CYP3A4CYP2C9HPGDOPRM1 | |
| SCHEMBL6374535 | 0.85 | OPRD1 (0.68) | CYP1A2CYP3A4CYP2C9HPGDOPRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1469850-A4 | METHOD OF TREATING SEXUAL DYSFUNCTIONS WITH DELTA OPIOID RECEPTOR AGONIST COMPOUNDS | ARDENT PHARMACEUTICALS INC (US) | 2008-03-12 | — | — | EP | disclosed |
| EP-1469850-A1 | METHOD OF TREATING SEXUAL DYSFUNCTIONS WITH DELTA OPIOID RECEPTOR AGONIST COMPOUNDS | Ardent Pharmaceuticals, Inc. (US) | 2004-10-27 | — | — | EP | disclosed |
| WO-2003057223-A1 | METHOD OF TREATING SEXUAL DYSFUNCTIONS WITH DELTA OPIOID RECEPTOR AGONIST COMPOUNDS | ARDENT PHARMACEUTICALS, INC. (US) | 2003-07-17 | — | — | WO | disclosed |